BUSINESS AREA
Medtech
In the Medtech business area, the subsidiaries offer products and services in the field of medical technology, as well as assistive equipment and digital solutions for home care. Medtech has two business units, Hospital and Homecare. The Medtech offering mainly focuses on publicly funded healthcare, home care and social care in Europe.
| Q2 | Q2 | ∆ | Jan-Jun | Jan-Jun | ∆ | Jul 2025- | Full year | |
| SEKm | 2026 | 2025 | % | 2026 | 2025 | % | Jun 2026 | 2025 |
| Net sales | 1,666 | 1,594 | 5 | 3,327 | 3,308 | 1 | 6,514 | 6,495 |
| Organic growth, % | 3 | 2 | 1 | 1 | 2 | |||
| EBITA | 213 | 198 | 7 | 425 | 429 | -1 | 960 | 964 |
| EBITA margin, % | 12.8 | 12.4 | 12.8 | 13.0 | 14.7 | 14.8 |
Net sales in Medtech by percent to SEK million (). Organic growth amounted to percent and acquired growth to percent. Organic growth was negatively impacted by the divestment of the endoscopy business in the UK in December 2025, corresponding to approximately SEK 30 million. Adjusted for the divestment, organic growth amounted to 5 percent. Exchange rate effects had a marginal negative impact on net sales during the quarter.
EBITA by percent to SEK million (), corresponding to an EBITA margin of percent (). Exchange rate effects had a marginal negative impact on EBITA during the quarter.
Medtech’s net sales amounted to SEK million (). Adjusted for exchange rate changes, net sales increased by 3 percent, of which organic growth amounted to percent and acquired growth to percent. Adjusted for the divestment of the endoscopy business in the UK, organic growth amounted to 3 percent. Exchange rate changes had a impact on net sales of SEK million, corresponding to percent.
EBITA by percent to SEK million (), corresponding to an EBITA margin of percent (). Exchange rate changes had a impact on EBITA of SEK million, corresponding to percent.
Margins in Medtech strengthened during the quarter, to a large extent as a result of the ongoing work to increase the share of advanced products in the portfolio.
Growth and profitability were strong in the Nordic countries. In Spain, underlying growth was good, but sales development was negatively affected by week-long doctors’ strikes in April, May and June. In the United Kingdom, sales development was weak, mainly due to a continued subdued market for capital goods. However, the order book for capital goods is strong.
Within Homecare, a number of improvement measures have been implemented in recent months. These measures have yielded good results, while simultaneously demand has increased. During the second quarter, Homecare reported strong growth and a clearly improved margin trend.
Improvement initiatives within ophthalmic surgery have been under way for an extended period and have included cost reductions, organisational changes, updates to the product portfolios and an increased sales focus. These initiatives have yielded results, and the companies within ophthalmic surgery have now demonstrated a clearly positive trend for some time.
